Prognostic value of non-alcoholic fatty liver disease in stage II/III breast cancer patients who received neoadjuvant chemotherapy

被引：1
|
作者：
Yang, Y.
Lee, K-H
Kim, T-Y
Han, S-W
Oh, D-Y
Kim, T-Y
Han, W.
Moon, H-G
Park, I. A.
Noh, D-Y
Im, S-A
机构：
[1] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P1-10-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-10-11
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic role of EGFR in stage II or III breast cancer patients who received neoadjuvant chemotherapy.
    Keam, B.
    Kim, H-J
    Oh, D-Y
    Lee, S-H
    Kim, D-W
    Han, W.
    Im, S-A
    Kim, T-Y
    Park, IAe
    Noh, D-Y
    Heo, D. S.
    Bang, Y-J
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S93 - S93
  • [2] STUDY OF PATIENTS WITH STAGE III BREAST CANCER WHO RECEIVED NEOADJUVANT CHEMOTHERAPY
    Iwakuma, N.
    Toh, U.
    Takahashi, R.
    Mishima, M.
    Takenaka, M.
    Koura, K.
    Fujii, T.
    Shirouzu, K.
    BREAST, 2013, 22 : S102 - S102
  • [3] Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
    Kim, Hyori
    Youk, Jeonghwan
    Yang, Yaewon
    Kim, Tae-Yong
    Min, Ahrum
    Ham, Hye-Seon
    Cho, Seongcheol
    Lee, Kyung-Hun
    Keam, Bhumsuk
    Han, Sae-Won
    Oh, Do-Youn
    Ryu, Han Suk
    Han, Wonshik
    Park, In Ae
    Kim, Tae-You
    Noh, Dong-Young
    Im, Seock-Ah
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (03) : 707 - 714
  • [4] Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
    Hyori Kim
    Jeonghwan Youk
    Yaewon Yang
    Tae-Yong Kim
    Ahrum Min
    Hye-Seon Ham
    Seongcheol Cho
    Kyung-Hun Lee
    Bhumsuk Keam
    Sae-Won Han
    Do-Youn Oh
    Han Suk Ryu
    Wonshik Han
    In Ae Park
    Tae-You Kim
    Dong-Young Noh
    Seock-Ah Im
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 707 - 714
  • [5] Prognostic value of non-alcoholic fatty liver disease in the elderly patients
    Tallarico, Viola
    Recinella, Guerino
    Magalotti, Donatella
    Muscari, Antonio
    Zoli, Marco
    Bianchi, Giampaolo
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 32 (12) : 2657 - 2665
  • [6] Prognostic value of non-alcoholic fatty liver disease in the elderly patients
    Viola Tallarico
    Guerino Recinella
    Donatella Magalotti
    Antonio Muscari
    Marco Zoli
    Giampaolo Bianchi
    Aging Clinical and Experimental Research, 2020, 32 : 2657 - 2665
  • [7] Prognostic factors in patients with operable breast cancer who received neoadjuvant chemotherapy
    Horiguchi, J.
    Takata, D.
    Nagaoka, R.
    Fujii, T.
    Sato, A.
    Tokiniwa, H.
    Higuchi, T.
    Uchida, S.
    Tsuboi, M.
    Yajima, R.
    Kikuchi, M.
    Ino, Y.
    Oyama, T.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S94 - S94
  • [8] Serial liver transaminases have no prognostic value in non-alcoholic fatty liver disease
    Uhanova, Julia
    Minuk, Gerald
    Premji, Kamila
    Chandok, Natasha
    CANADIAN LIVER JOURNAL, 2019, 2 (01): : 19 - 22
  • [9] Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease
    Vakhrushev, Ya. M.
    Suchkova, E. V.
    Lukashevich, A. P.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (12) : 31 - 35
  • [10] Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
    Wu, San-Gang
    Li, Qun
    Zhou, Juan
    Sun, Jia-Yuan
    Li, Feng-Yan
    Lin, Qin
    Lin, Huan-Xin
    Gaun, Xun-Xing
    He, Zhen-Yu
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 757 - 764
12345